9H4-48942-35194
4 vaccinations
10 coded responses
49 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 537 / WI
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Health check-in — day 0, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-07
- 2021-03-08
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: The headache may be due to my migraine condition.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
-
2021-03-27
Dose 2 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
- 2021-04-17
-
2021-04-24
Survey response — day 28, dose 2MedDRA: Emergency care, Haemorrhage — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: I had to be treated at the emergency room for a bleeding ovarian cystMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-01
- 2021-05-08
- 2021-06-26
- 2021-09-25
-
2021-11-12
Dose 3 — Pfizer-BioNTech
-
2021-11-15
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen axillary lymph nodes on the armpit of the injection site arm.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Axillary lymph node swelling in the injected arm armpit.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Axillary lymph node swelling in injection armMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Fever · HeadacheFree text: Minor axillary lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Survey response — day 7, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Axillary lymph node swellingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-23
- 2021-12-24
- 2022-02-11
-
2022-05-13
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for COVID-19; symptoms were sore throat, congestion, cough, and fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-17
- 2022-05-17
- 2022-05-18
- 2022-05-18
-
2022-09-24
Dose 4 — Pfizer-BioNTech
-
2022-09-26
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph node near injection siteMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-24
- 2022-10-31
- 2022-11-05
- 2022-12-24
-
2023-03-25
Survey response — 6 months, dose 4MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-25
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2023-03-27
- 2023-03-27
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-24 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): The headache may be due to my migraine condition.
Release 7 — day 28, dose 2
Symptoms: I had to be treated at the emergency room for a bleeding ovarian cyst
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen axillary lymph nodes on the armpit of the injection site arm.
Systemic reaction (other): Axillary lymph node swelling in the injected arm armpit.
Systemic reaction (other): Axillary lymph node swelling in injection arm
Systemic reaction (other): Minor axillary lymph node swelling
Release 10 — day 7, dose 3
Systemic reaction (other): Axillary lymph node swelling
Release 11 — 6 months, dose 3
Symptoms: Tested positive for COVID-19; symptoms were sore throat, congestion, cough, and fatigue.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen lymph node near injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Haemorrhage | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release